Intracranial Tumor Control After Immune-Related Adverse Events and Discontinuation of Immunotherapy for Melanoma.
Zhang M, Rodrigues AJ, Bhambhvani HP, Fatemi P, Pollom EL, Gibbs IC, Thomas RP, Soltys SG, Hancock SL, Chang SD, Reddy SA, Gephart MH, Li G.
Zhang M, et al. Among authors: fatemi p.
World Neurosurg. 2020 Dec;144:e316-e325. doi: 10.1016/j.wneu.2020.08.124. Epub 2020 Aug 24.
World Neurosurg. 2020.
PMID: 32853767